Acute febrile neutrophilic dermatosis and Psoriasis
Psoriasis is reported only by a few people with Acute febrile neutrophilic dermatosis.
The study analyzes which people have Psoriasis with Acute febrile neutrophilic dermatosis. It is created by eHealthMe based on 1 person who has Psoriasis and Acute febrile neutrophilic dermatosis from the Food and Drug Administration (FDA), and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
1 person who has Acute Febrile Neutrophilic Dermatosis and Psoriasis is studied.
What is Acute febrile neutrophilic dermatosis?
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender) is found to be associated with 531 drugs and 351 conditions by eHealthMe.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 2,128 drugs and 1,497 conditions by eHealthMe.
Number of Psoriasis in Acute febrile neutrophilic dermatosis reports submitted per year:
Gender of people who have Acute Febrile Neutrophilic Dermatosis and experienced Psoriasis *:
- female: 100 %
- male: 0.0 %
Age of people who have Acute Febrile Neutrophilic Dermatosis and experienced Psoriasis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common drugs taken by these people *:
- Stelara: 1 person, 100.00%
Common symptoms for these people *:
- Hyperhidrosis (abnormally increased sweating): 1 person, 100.00%
- Fainting (loss of consciousness and postural tone): 1 person, 100.00%
- Drug Ineffective: 1 person, 100.00%
- Cardiac Disorder: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Psoriasis?Check whether Psoriasis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Treatments, associated drugs and conditions:
COVID vaccines that are related to Psoriasis:
- Psoriasis in Moderna COVID Vaccine
- Psoriasis in Pfizer BioNTech Covid Vaccine
- Psoriasis in Johnson and Johnson Covid Vaccine
Common drugs associated with Psoriasis:
All the drugs that are associated with Psoriasis:
- Psoriasis (2,128 drugs)
Common conditions associated with Psoriasis:
All the conditions that are associated with Psoriasis:
- Psoriasis (1,497 conditions)
How the study uses the data?
The study is based on Psoriasis and Acute febrile neutrophilic dermatosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.